Trial
NCT02624310
A Study of Norepinephrine in Patients With Congenital Insensitivity to Pain and Anhidrosis
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
NYU Langone Health
Collaborators
—
Condition
HSAN Type IV
Intervention
Droxidopa (L-DOPS)
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-09-12